Gains Unique Microfluidics-Based Diagnostic Technology Platform
The Claros technology requires only a finger stick drop of blood introduced into the cassette, which can multiplex up to 20 separate tests with unparalleled ease. Claros has successfully validated the technology for urology and infectious disease market applications, and this validation will serve as a bridge to other test panels for infectious disease, cardiology, women's health, companion diagnostics, and almost any field of blood diagnostics.
"Claros presents an ideal strategic fit for OPKO," said
"There are tremendous synergies between the Claros and OPKO technologies
which can position OPKO to be an important provider of diagnostics
OPKO is a multi-national biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large and rapidly growing medical markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies.
This press release contains "forward-looking statements," as that
term is defined under the Private Securities Litigation Reform Act of
1995 (PSLRA), which statements may be identified by words such as
"expects," "plans," "projects," "will," "may," "anticipates,"
"believes," "should," "intends," "estimates," and other words of similar
meaning, including statements regarding the Claros platform and product
candidates, the platform's ability to transition complex
immunoassays from the reference laboratory to the physician's office and
to multiplex tests with unparalleled ease, the utility of the product
for infectious disease, women's health, companion diagnostics and other
blood diagnostics markets, OPKO's ability to use the Claros platform to
achieve near term commercialization opportunities and combine the Claros
platform with OPKO's biomarker technology, the Claros technology serving
as an ideal platform for use as companion diagnostics and the
opportunity to play a significant role in the worldwide diagnostics
business, as well as other non-historical statements about our
expectations, beliefs or intentions regarding our business, technologies
and products, financial condition, strategies or prospects. Many factors
could cause our actual activities or results to differ materially from
the activities and results anticipated in forward-looking statements.
These factors include those described in our filings with the
News Provided by Acquire Media